UBS Group AG
NYSE:UBSBanks - Diversified
+$1.10 today
- Market cap
- $139.77B
- Beta
- 0.84
- P/E (TTM)
- 20.2
- EPS (TTM)
- $2.52
- Dividend yield
- 2.12%
Volume 1.72M
Average 2.52M
UBS Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
UBS Group AGNYSE: UBS
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How UBS compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for UBS, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jul 2026 | CA$0 CAD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | ¥0 JPY | — | — | 0.0% | |
| LTM Jul 2026 | CA$0 CAD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | €0 EUR | — | — | 0.0% | |
| Peer median (excluding UBS) | — | — | — | 0.0% | |
Competitors are the stored peer set for UBS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 35.03B | 36.82B | 57.38B | 74.22B | 73.84B |
| Cost of Revenue | 2.84B | 6.09B | 25.02B | 33.13B | 27.07B |
| Gross Profit | 32.18B | 30.73B | 32.36B | 41.09B | 46.77B |
| Gross Margin | 91.9% | 83.5% | 56.4% | 55.4% | 63.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 19.98B | 19.71B | 23.43B | 30.13B | 31.02B |
| Operating Expenses | 23.51B | 21.85B | 8.18B | 34.9B | 37.92B |
| Depreciation & Amortization | 2.12B | 2.06B | 3.23B | 3.8B | 3.53B |
| EBITDA | 10.79B | 10.94B | 27.4B | 9.99B | 12.38B |
| EBITDA Margin | 30.8% | 29.7% | 47.7% | 13.5% | 16.8% |
| Operating Income | 8.67B | 8.88B | 24.17B | 6.19B | 8.85B |
| Operating Margin | 24.8% | 24.1% | 42.1% | 8.3% | 12.0% |
| Interest Income | 9.11B | 12.19B | 30.38B | 39.08B | 34.29B |
| Interest Expense | 2.98B | 6.07B | 24.14B | 32.63B | 26.55B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 8.67B | 8.88B | 24.17B | 6.19B | 8.85B |
| Pre-Tax Margin | 24.8% | 24.1% | 42.1% | 8.3% | 12.0% |
| Income Tax Expense | 1.83B | 1.8B | 746.8M | 1.52B | 1.06B |
| Net Income | 6.82B | 7.05B | 23.41B | 4.62B | 7.77B |
| Net Margin | 19.5% | 19.2% | 40.8% | 6.2% | 10.5% |
| EPS (Basic) | 2.14 | 2.34 | 8.30 | 1.59 | 2.46 |
| EPS (Diluted) | 2.06 | 2.25 | 8.30 | 1.52 | 2.36 |
| Weighted Avg Shares | 3.62B | 3.39B | 3.3B | 3.35B | 3.18B |
| Weighted Avg Shares (Diluted) | 3.63B | 3.4B | 3.3B | 3.35B | 3.31B |
UBS Group AG
NYSE:UBS
Intrinsic Alpha fair value
Locked
Current Price
$45.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.